FDA Should Deem Atorvastatin Capsule ANDAs Suitable For Submission – Citizen Petition
This article was originally published in The Pink Sheet Daily
Executive Summary
Atorvastatin capsules would be bioequivalent to Pfizer’s Lipitor tablets since the dosage form is the only proposed change to labeling, Lachman Consultant Services says in citizen petition.